undamentalytics Newsletter
Sign in

Nexalin Technology, Inc. cash flow statement

In fiscal 2025, Nexalin Technology, Inc.'s operations generated −$5.0m of cash.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−1,077−2,216−3,835−3,944−4,958−6,129
Depreciation and amortisation111———
Stock-based pay4,4782712,4133,5613,1232,801
Shares issued1,4348,545—4,5164,646—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: NXL vs QTEXNXL vs PAVMNXL vs POAS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nexalin Technology, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nexalin Technology, Inc.